Agouron Pharmaceuticals' of the present day advertisements for the protease inhibitor Viracept reveal a first in HIV unsalable article promotion--the inclusion of a warning that states.

Agouron Pharmaceuticals' of the present day advertisements for the protease inhibitor Viracept reveal a first in HIV unsalable article promotion--the inclusion of a warning that states, "HIV physics do not cure HIV infection or obviate you from spreading the virus."

Just sum of two units weeks after the Food and remedy Administration mandated that HIV remedy ads include the notice and stop offering up "unrealistic" representations of the public with HIV, Agouron became the first drugmaker to comply

Agouron began crafting its series of print ads showcasing real HIV-positive people--not gauges or actors--last October, said manager of consumer marketing Catherine O'Connor. And because the ad campaign qualifieds nearly all of the novel FDA guidelines--a "happy coincidence," O'Connor said--the drugmaker had single to insert the printed warning into its ads. if it be not that other pharmaceutical companies may not have as it is an easy task in complying with the regulations.

"Our campaign pretends to be right on target," O'Connor noted. "Some of the other scarecrows may have to reinvent the wheel."

...

Home